Millennium Management’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
Other funds holding NEOS
SCM
DM
BCM
Millennium Management's NEOS Position: Q4 2020 in Review
Millennium Management sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 15,770 shares — an estimated $8 sold.
Millennium Management first reported a position in NEOS in Q3 2015 and held it in 17 quarters. The position peaked at $9.78M in Q3 2017. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.
- Millennium Management reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
- Millennium Management sold 15,770 Neos Therapeutics, Inc shares in Q4 2020, an estimated $8.
- Millennium Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 17 quarters.
- Millennium Management's Neos Therapeutics, Inc position peaked at $9.78M in Q3 2017.
- 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.